Occurrence and predictors of the fatigue in high-grade glioma patients
- 20 February 2015
- journal article
- Published by Springer Nature in Neurological Sciences
- Vol. 36 (8) , 1363-1369
Abstract
A better knowledge of the fatigue could be of the greatest importance for the high-grade glioma (HGG) patients, who are a unique and vulnerable population. The aim of this study was to evaluate the occurrence and the predictors of the fatigue in HGG patients, using a specific fatigue scale. The study was designed as a cross-sectional study. The study population included sixty-seven consecutive outpatients with HGG. We used these measures: Brief Fatigue Inventory, Karnofsky Performance Scale, Functional Independence Measure, Brief Psychiatric Rating Scale and Psychological Distress Inventory and SF-36, EORTC QLQ-30 and EORTC QLQ-BN20 for quality of life (QoL). Sixteen out of sixty-seven (23.9 %) patients were affected by Anaplastic Astrocytoma and 51/67 (76.1 %) by Glioblastoma Multiforme. About one-third (36.2 %) of patients had a clinically relevant fatigue (Brief Fatigue Inventory ≥3). In regression analysis, physical and mental aspects of QoL were statistically significant related with fatigue (p < 0.01 and p < 0.02, respectively). Our data underlined the relevant occurrence of fatigue in HGG patients and support the development of further studies exploring a tailored rehabilitation program.Keywords
This publication has 31 references indexed in Scilit:
- Health-related quality of life in high-grade glioma patients: a prospective single-center studySupportive Care in Cancer, 2011
- Clinically relevant fatigue in recurrence-free prostate cancer survivorsAnnals of Oncology, 2011
- Risk factors for fatigue severity in primary brain tumor patientsCancer, 2010
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Impact of brain tumour treatment on quality of lifeJournal of Neurology, 2002
- Effect of disease burden on health-related quality of life in patients with malignant gliomasNeuro-Oncology, 2000
- Fatique Patterns Observed in Patients Receiving Chemotherapy and RadiotherapyCancer Investigation, 2000
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992